23 July 2021 (Friday) - Current Thinking on MDS

The nice people at the American Society of Hematology sent an update today focussing of the latest treatments for myelodysplastic syndromes. All rather clinical, but all useful stuff…

Rusfertide Helps Patients With Polycythemia Vera Avoid Phlebotomy
Patients with polycythemia vera who received rusfertide were able to avoid therapeutic phlebotomy for seven months, even among those with high-risk disease, according to research presented at EHA2021 Virtual.
Avapritinib Approved for Advanced Systemic Mastocytosis
The FDA has approved avapritinib for the treatment of adult patients with advanced systemic mastocytosis, systemic mastocytosis with an associated hematologic neoplasm, and mast cell leukemia.
Exploring Venetoclax Plus Azacitidine in CMML and MPNs
Results from two recently published studies investigated the treatment combination in patients with chronic myelomonocytic leukemia and myeloproliferative neoplasms, finding that venetoclax plus azacitidine led to high response rates in these disease settings.


No comments:

Post a Comment